|
| |
Welcome to the summer edition of the ESTIV 2021 Newsletter summarising the news and activities related to ESTIV society and its members. |
|
|
|
|
 | |
Mrs. Sabrina Madiedo-Podvršan has been selected by the ESTIV Awards committee as the recipient of the 2021 Best Poster Award at the JRC Summer School in recognition of her outstanding poster presentation of a project leading to the development of the new in vitro lung/liver device for risk assessment of inhaled xenobiotics. Congratulations!
|
|
|
|
|
| |
|
It is with much regret that we announce the passing of Dr Bob Combes, past ESTIV president (1998-2002), close friend and colleague to many ESTIV members. Dr Bob Combes was a strong supporter of the European 3R community over many years. He will be greatly missed.
|
|
|
|
|
|
|
|
 | |
Dr. Sandra Coecke from the European Commission Joint Research Centre is the recipient of the Björn Ekwall Memorial Award for the year 2020. The award recognises her work on the development and validation of new in vitro cell- and tissue-based methods for in vitro toxicity testing for the replacement of animal experiments. Sandra gave recently an interview for WC11 podcast.
|
|
|
|
|
| |
|
ESTIV will grant Best poster award, including 500€ and 1 year (2021) free ESTIV membership, to a Ph.D. student or young scientist (≤ 35 years old) presenting her/his research work in the field of in vitro or in silico toxicology per poster as the first author during the 11th World Congress on Alternatives and Animal Use in the Life Sciences taking place 22-26 August 2021 in Maastricht, The Netherlands.
|
|
|
|
|
|
| |
Joint ASCCT/ESTIV webinars
The July Joint ASCCT/ESTIV webinar: Bridging toxicology and research: COVID-19 initiatives, featuring Marco Travaglio, PhD student, MRC Toxicology Unit, School of Biological Sciences, University of Cambridget and Maria João Amorim, PhD, Instituto Gulbenkian de Ciência, is now available for viewing.
|
|
|
|
|
|
|
|
CIAO - COVID-19 Using the Adverse Outcome Pathway Framework
| |
 |
The CIAO project is helping to make sense of the enormous amount of biological information on COVID-19 by exploiting a well-established knowledge framework called Adverse Outcome Pathways (AOP). The CIAO project team already comprises more than 60 scientists worldwide and is co-organising webinars in July and in September with Humane Society International and Physicians Committee for Responsible Medicine to present the project and the results obtained so far.
|
|
|
|
|
| |
Meeting report
Several ESTIV members participated as invited speakers at the Second Virtual Summer School "Alternative methods in science - Towards model complexity" organised by the Como Lake School of Advanced Studies.
|
|
|
|
|
|
|
|
ASCCT Annual meeting
 | |
10th Annual ASCCT Meeting will be taking place virtually October 12th – 14th, 2021! Visit our event page for additional information. This year’s theme will be Practical applications of new tools in toxicology, and abstracts for oral and poster presentations are now invited to be submitted. Any submissions related to in vitro and in silico toxicology, broadly defined and including science, policy, and regulatory topics, are welcome.
|
|
|
|
|
|
|
ESTIV involved in Horizont 2020 project
 | |
ESTIV will be one of the major dissemination channels in the ONTOX project, which stands for “ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next-generation risk assessment”.
The ONTOX project is supported by a European Horizon2020 grant of more than €17 million, and will generate innovative methods to evaluate the safety of chemical substances without using laboratory animals. The ONTOX consortium consists of 18 European and American partners, and more than 60 scientists, many of them active members of ESTIV. The ONTOX project will kick off on 1 May 2021 for a period of 5 years and will be coordinated by Prof. Mathieu Vinken (Vrije Universiteit Brussel-Belgium), past-president of ESTIV.
|
|
|
|
|
|
|
ESTIV Applied training course
| |
 |
Due to the repeated rise of Covid 19 and planned travel/meetings res-trictions in many of EU countires, the ESTIV Applied Training course has been postponed to June 5-10, 2022. We all hope, that the situation will improve till them and we will be able to provide full training programm as planned and announced at the ESTIV website. For more information about the course and speakers please visit the ESTIV website.
|
|
|
|
|
|
|
Save the date: MPS World summit - virtual meeting
 | |
The MPS World Summit will bring together a global audience—including institutions (government, health foundations, charities), the academic research community (universities, research institutes), environmental and human toxicity researchers, the pharmaceutical and other industries (cosmetics, chemical, and food industries), medical centers and practitioners, patient associations, and policy makers and testing centers—in a series of global conferences to create A roadmap for MPS technologies
|
|
|
|
|
| |
ESTIV welcomes two new corporate members !
|
|
|
|
| |
Symrise
Symrise is a global supplier of fragrances, flavors, food, nutrition and cosmetic ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, pharmaceuticals and producers of nutritional supplements and pet food. Its sales of € 3.5 billion in the 2020 fiscal year make Symrise a leading global provider. Headquartered in Holzminden, Germany, the Group is represented by more than 100 locations in Europe, Africa, the Middle East, Asia, the United States and Latin America. Symrise works with its clients to develop new ideas and market-ready concepts for products that form an integral part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process. In addition, we have set up an animal testing policy in 2009 that aims to minimize such testing and we are promoting alternative approaches wherever possible.
For more information visit:
www.symrise.com
|
React4Life
React4life is an Italian startup that developed MIVO® – Multi In Vitro Organ, a patented microphysiological system (MPS) able to reproduce portions of the human body improving the reliability of the testing outcome. It can easily accommodate and cultivate 3D human tissues, organoids or biopsies to suit every testing needs. MIVO® can be used as bioreactor, for enhancing tissues conditions and prolonging lifetime, for advanced drug testing assays on 3D tissues, for discovering new therapeutic approaches, and for basic research, without involving animal use. It is individually blistered, sterile, disposable, immediately ready-to-use. For more information visit:
www.react4life.com
|
|
|
|
|
|
| |
ESTIV CORPORATE MEMBERS
Click on the picture below to learn more about all ESTIV Corporate members and their activities!
|
|
|
|
| |
How Non-Animal Testing Can Reshape Health and Environment Policies
An excellent article written by Jeanne Laperrouze - Altertox
|
|
|
|
|
|
| |
US SOT Award for SenzaGen
SenzaGen was awarded MDCPSS Best Overall Abstract Award Winner at this year’s SOT for the poster “Applicability Domain of the GARD™skin Medical Device Test for In Vitro Skin Sensitization Testing of Medical Devices”
|
|
|
|
|
|
| |
EPISKIN Academy webinar
2nd EPISKIN Academy webinar "Addressing In Vitro Eye Irritation With The Skinethic Hce : Recent Developments And Live Lab Session" recording is now available!
|
|
|
|
|
|
| |
MEMBERS´ PUBLICATIONS
See the ist of papers published by ESTIV memebers and sub-mitted to ESTIV news.
|
|
UPCOMING MEETINGS
List of the upcoming meetings of the ESTIV memebers interest.
|
ESTIV BOARD 2021
Learn more about the ESTIV Board and sub-comittes.
|
|
|
|
|
|
